IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM
ID: 75N93024R00017Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (AN12)

Original Source

https://sam.gov/opp/e7908d74caf340fba8b451ba6e9395e2/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the Immune Epitope Database and Analysis Program, aimed at enhancing research capabilities related to infectious diseases, allergies, and autoimmunity. The program seeks to provide a comprehensive resource for researchers to explore data on antibody and T-cell epitopes, with a focus on maintaining high standards of compliance and transparency in research practices. Proposals are due by November 19, 2024, with a base performance period from October 15, 2025, to October 14, 2026, and potential extensions for up to four additional years. Interested parties can contact Brandon de White at whitebra@niaid.nih.gov or Tom Bahrami at bahramit@niaid.nih.gov for further information.

    Files
    Title
    Posted
    75N93024R00017.pdf
    The National Institutes of Health (NIH) issued a Request for Proposal (RFP) aimed at continuing support for the Immune Epitope Database and Analysis Program. The RFP outlines requirements for proposals to be submitted by 11/19/2024. This initiative provides researchers with a resource to explore data on antibody and T-cell epitopes related to infectious diseases, allergies, and autoimmunity. The document specifies the submission and evaluation process, including the necessity for offers to be registered in the System for Award Management (SAM). Key details include the base period of performance from 10/15/2025 to 10/14/2026, with options for extensions in subsequent years. Reporting requirements specify electronic submissions conforming to Section 508 standards, and continuous updates on technical progress are mandated. Special contract provisions address the protection of human subjects, NIH reproducibility policies, and acknowledgement of federal funding. The solicitation emphasizes compliance with various regulations including financial conflict of interest reporting and information security standards, highlighting the government’s commitment to transparency and accountability in its funded research activities. Overall, this RFP reflects NIH's efforts to bolster biomedical research infrastructure while safeguarding sensitive information.
    Amendment 1 75N93024R00017.pdf
    Amendment #1 to RFP-NIAID-DAIT-75N93024R00017, issued on September 17, 2024, updates the solicitation regarding a contract aimed at providing specific services outlined in the Statement of Work. The proposal due date remains unchanged, set for November 19, 2024, at 3:00 PM. This amendment primarily addresses questions from potential offerors, specifically regarding budget and effort levels. The amended section specifies that the government requires 20,800 direct labor hours for the base year and each of the first four optional years, with an additional 1,040 hours available for each subsequent level of effort if options beyond four are exercised, cumulatively totaling 31,200 hours per year. Offerors have discretion over the proposed labor mix to align with their technical approach. The document underscores the government's commitment to transparency by inviting further questions and clarifications while emphasizing the necessity for potential bidders to acknowledge receipt of the amendment to avoid rejection. This amendment represents a typical practice in federal RFPs, ensuring applicants have the latest information to appropriately prepare their proposals.
    Lifecycle
    Title
    Type
    IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM
    Currently viewing
    Solicitation
    Similar Opportunities
    NIAID Virology Quality Assurance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking qualified small business sources for the NIAID Virology Quality Assurance (VQA) program. The primary objective is to establish a comprehensive quality assessment program for virologic assays related to HIV and other viral pathogens, ensuring the validity and reliability of laboratory data across approximately 110 laboratories globally. This initiative is crucial for maintaining the scientific integrity of ongoing and future studies concerning HIV diagnosis, treatment, and emerging viral pathogens. Interested parties must submit their capability statements by September 26, 2024, to Shawnice Williams at shawnice.williams@nih.gov, with a focus on demonstrating relevant experience and qualifications.
    A--Request for Proposals - Phase I Clinical Trials
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Phase I clinical trials aimed at developing small molecule and biologics therapeutics, as outlined in RFP No. 75N95024R00086. The selected contractor will be responsible for comprehensive services including protocol development, trial management, and reporting to regulatory agencies, with a focus on safety, tolerability, and pharmacokinetics of the investigational therapeutics. This initiative is crucial for advancing therapeutic development in the field of neurology, ensuring compliance with FDA and ICH GCP standards throughout the trial process. Proposals are due by October 3, 2024, with a contract performance period from April 1, 2025, to March 31, 2035, and a maximum contract value of $233,227,446. Interested parties can contact Evan C. Feely at evan.feely@nih.gov or +1 301 827 5301 for further information.
    A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) seek proposals from small businesses for innovative research projects under the Small Business Innovation Research (SBIR) program. The upcoming solicitation, PHS-2025-1, will open on August 2, 2024, with a closing date of October 18, 2024, and aims to foster healthcare technological innovation and commercialization. Research topics span cancer research, aging, and various health concerns. Offerors must demonstrate the technical and commercial viability of their proposals. This solicitation invites applications for Phase I, Fast Track, and Direct to Phase II projects, with evaluations based on scientific merit, commercial potential, and performance quality. Successful small businesses could receive funding for their research initiatives, contributing to NIH and CDC mission objectives.
    A--BPCA Pediatric Trials Network
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for an Indefinite Quantity Contract to establish and manage the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network. This initiative aims to create a robust infrastructure for conducting pediatric clinical trials, emphasizing compliance with federal regulations and ethical standards in research practices. The contract, which has a performance period from May 19, 2025, to May 18, 2033, offers a minimum compensation of $2,500 and a maximum potential value of $149 million, contingent on successful performance. Proposals are due by November 4, 2024, and interested parties can contact Elizabeth J. Osinski at eo43m@nih.gov or 240-550-5028 for further information.
    Genomics Sequencing Services for the NIAID Centralized Sequencing Program
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotations for genomics sequencing services to support its Centralized Sequencing Program (CSP). The procurement aims to acquire comprehensive clinical whole genome sequencing services, including interpretation and reporting, to enhance the understanding of infectious diseases and improve patient care, with a focus on delivering results within a four-week turnaround time. This initiative is critical for advancing clinical research and understanding the genetic basis of diseases, as the NIAID conducts numerous clinical trials annually. Interested vendors must submit their quotes by September 23, 2024, and direct any inquiries to Seth Schaffer at seth.schaffer@nih.gov or Linda Smith at linda.smith2@nih.gov.
    DRAFT Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) exploration topic. This initiative aims to enhance access to curative cell therapies for pediatric patients with rare genetic diseases by developing novel quality assurance mechanisms at Academic Medical Centers (AMCs) over a structured 24-month program. The program will focus on identifying manufacturing variability, improving batch quality through signature identification methodologies, and creating statistical tools to guide production decisions, ultimately streamlining the development of small batch autologous cell therapies. Proposals are due by October 22, 2024, and interested parties should direct inquiries to the designated email address provided in the solicitation.
    Surface Plasmon Resonance (SPR) Instrument- Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for a Surface Plasmon Resonance (SPR) Instrument, either brand name or equal, to support its Vaccine Research Center's structural biology efforts. The procurement aims to acquire a high-throughput SPR instrument that meets specific technical requirements, including dimensions, weight, temperature ranges, and data collection capabilities, to facilitate biophysical and structural analysis of macromolecules. This equipment is critical for advancing research in infectious diseases and vaccine development. Interested vendors must submit their quotes by 4:30 PM EST on September 19, 2024, to Hershea Vance at hershea.vance@nih.gov, and ensure compliance with all specified requirements and clauses outlined in the solicitation documents.
    Hitachi HT7800 Transmission Electron Microscope
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for the procurement of a Hitachi HT7800 Transmission Electron Microscope. This acquisition aims to support the development of antibody therapeutics and the design of vaccines and antivirals, which are critical for ongoing research at the Vaccine Research Center (VRC). The procurement is governed by FAR Simplified Acquisition Procedures, and the selected vendor will be required to deliver the microscope within 30 days of award, with installation and training to be completed by March 25, 2024. Interested vendors must submit their quotes by 12:00 PM EST on September 23, 2024, to Hershea Vance at hershea.vance@nih.gov, and ensure compliance with all specified requirements and clauses outlined in the solicitation.
    Automated Liquid Handling Systems– Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two automated liquid handling systems, either brand name or equal, to support the Vaccine Production Program (VPP) at the National Institute of Allergy and Infectious Diseases (NIAID). These systems are critical for high-throughput, microscale protein purification and product characterization, which are essential for developing vaccines against various pathogens, including HIV and SARS-COV-2. Interested vendors must submit their quotes by 12:00 PM EST on September 23, 2024, to Daveta H. Brown at daveta.brown@nih.gov, ensuring compliance with all specified requirements and regulations outlined in the solicitation documents.
    High-content, Multiomic Imaging System for Spatial Biology Research
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for a high-content, multiomic imaging system to enhance spatial biology research focused on tick-borne infectious diseases. The procurement requires a comprehensive multiomics platform, including a widefield epifluorescence microscope, a scientific CMOS high-resolution camera, a liquid handling station, and associated software, along with installation and training services. This acquisition is crucial for advancing research methodologies in public health and will be processed under Simplified Acquisition Procedures, with a firm-fixed-price purchase order anticipated. Interested offerors must submit their quotes by September 20, 2024, and can direct inquiries to Seth Schaffer at seth.schaffer@nih.gov or Tamara McDermott at tamara.mcdermott@nih.gov.